TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 303 filers reported holding TANDEM DIABETES CARE INC in Q3 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,693 | -91.4% | 14,718 | -89.8% | 0.01% | -92.2% |
| Q2 2023 | $3,538,962 | +35.0% | 144,212 | +123.4% | 0.08% | +20.3% |
| Q1 2023 | $2,622,025 | +33.3% | 64,566 | +47.5% | 0.06% | +16.4% |
| Q4 2022 | $1,967,012 | +356.4% | 43,760 | +386.4% | 0.06% | +323.1% |
| Q3 2022 | $431,000 | -48.0% | 8,997 | -35.8% | 0.01% | -51.9% |
| Q2 2022 | $829,000 | -46.9% | 14,005 | +4.4% | 0.03% | -43.8% |
| Q1 2022 | $1,560,000 | +53.1% | 13,417 | +98.1% | 0.05% | +45.5% |
| Q4 2021 | $1,019,000 | +307.6% | 6,773 | +164.0% | 0.03% | +200.0% |
| Q2 2021 | $250,000 | +22.5% | 2,566 | -25.9% | 0.01% | +175.0% |
| Q3 2019 | $204,000 | -66.5% | 3,464 | -63.3% | 0.00% | -60.0% |
| Q2 2019 | $609,000 | -54.4% | 9,446 | -55.1% | 0.01% | -50.0% |
| Q1 2019 | $1,335,000 | +71.4% | 21,019 | +2.5% | 0.02% | +66.7% |
| Q4 2018 | $779,000 | – | 20,514 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |